Literature DB >> 29423331

Transforming growth factor-β in stem cells and tissue homeostasis.

Xin Xu1, Liwei Zheng2, Quan Yuan3, Gehua Zhen4, Janet L Crane4,5, Xuedong Zhou1, Xu Cao4.   

Abstract

TGF-β 1-3 are unique multi-functional growth factors that are only expressed in mammals, and mainly secreted and stored as a latent complex in the extracellular matrix (ECM). The biological functions of TGF-β in adults can only be delivered after ligand activation, mostly in response to environmental perturbations. Although involved in multiple biological and pathological processes of the human body, the exact roles of TGF-β in maintaining stem cells and tissue homeostasis have not been well-documented until recent advances, which delineate their functions in a given context. Our recent findings, along with data reported by others, have clearly shown that temporal and spatial activation of TGF-β is involved in the recruitment of stem/progenitor cell participation in tissue regeneration/remodeling process, whereas sustained abnormalities in TGF-β ligand activation, regardless of genetic or environmental origin, will inevitably disrupt the normal physiology and lead to pathobiology of major diseases. Modulation of TGF-β signaling with different approaches has proven effective pre-clinically in the treatment of multiple pathologies such as sclerosis/fibrosis, tumor metastasis, osteoarthritis, and immune disorders. Thus, further elucidation of the mechanisms by which TGF-β is activated in different tissues/organs and how targeted cells respond in a context-dependent way can likely be translated with clinical benefits in the management of a broad range of diseases with the involvement of TGF-β.

Entities:  

Year:  2018        PMID: 29423331      PMCID: PMC5802812          DOI: 10.1038/s41413-017-0005-4

Source DB:  PubMed          Journal:  Bone Res        ISSN: 2095-4700            Impact factor:   13.567


  585 in total

1.  PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling.

Authors:  Xia Lin; Xueyan Duan; Yao-Yun Liang; Ying Su; Katharine H Wrighton; Jianyin Long; Min Hu; Candi M Davis; Jinrong Wang; F Charles Brunicardi; Yigong Shi; Ye-Guang Chen; Anming Meng; Xin-Hua Feng
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

Review 2.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

Review 3.  The latent transforming growth factor beta binding protein (LTBP) family.

Authors:  R Oklü; R Hesketh
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

4.  Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.

Authors:  S Dennler; S Itoh; D Vivien; P ten Dijke; S Huet; J M Gauthier
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

5.  Breast cancer cells interact with osteoblasts to support osteoclast formation.

Authors:  R J Thomas; T A Guise; J J Yin; J Elliott; N J Horwood; T J Martin; M T Gillespie
Journal:  Endocrinology       Date:  1999-10       Impact factor: 4.736

6.  Phase II trial of Belagenpumatucel-L, a TGF-beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients.

Authors:  J Nemunaitis; M Nemunaitis; N Senzer; P Snitz; C Bedell; P Kumar; B Pappen; P B Maples; D Shawler; H Fakhrai
Journal:  Cancer Gene Ther       Date:  2009-03-13       Impact factor: 5.987

7.  Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery.

Authors:  Anna L Mead; Tina T L Wong; M Francesca Cordeiro; Ian K Anderson; Peng T Khaw
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-08       Impact factor: 4.799

8.  Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.

Authors:  W A Border; N A Noble; T Yamamoto; J R Harper; Y u Yamaguchi; M D Pierschbacher; E Ruoslahti
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

9.  The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.

Authors:  Alessandro Sorrentino; Noopur Thakur; Susanne Grimsby; Anders Marcusson; Verena von Bulow; Norbert Schuster; Shouting Zhang; Carl-Henrik Heldin; Maréne Landström
Journal:  Nat Cell Biol       Date:  2008-08-31       Impact factor: 28.824

10.  Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway.

Authors:  Samy Lamouille; Rik Derynck
Journal:  J Cell Biol       Date:  2007-07-23       Impact factor: 10.539

View more
  99 in total

1.  TGF-β2/Smad3 Signaling Pathway Activation Through Enhancing VEGF and CD34 Ameliorates Cerebral Ischemia/Reperfusion Injury After Isoflurane Post-conditioning in Rats.

Authors:  Li Peng; Jiangwen Yin; Sheng Wang; Mingyue Ge; Ziwei Han; Yan Wang; Meng Zhang; Liping Xie; Yan Li
Journal:  Neurochem Res       Date:  2019-09-25       Impact factor: 3.996

2.  MSC-released TGF-β regulate α-SMA expression of myofibroblast during wound healing.

Authors:  Agung Putra; Iffan Alif; Nurfitriani Hamra; Octyana Santosa; Azizah Retno Kustiyah; Adi Muradi Muhar; Kiki Lukman
Journal:  J Stem Cells Regen Med       Date:  2020-12-11

Review 3.  Regenerative Therapy Using Umbilical Cord Serum.

Authors:  Nagarajan Maharajan; Gwang-Won Cho; Ji Hyun Choi; Chul Ho Jang
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

Review 4.  Exploring the Trans-Cleavage Activity of CRISPR-Cas12a (cpf1) for the Development of a Universal Electrochemical Biosensor.

Authors:  Yifan Dai; Rodrigo A Somoza; Liu Wang; Jean F Welter; Yan Li; Arnold I Caplan; Chung Chiun Liu
Journal:  Angew Chem Int Ed Engl       Date:  2019-10-17       Impact factor: 15.336

Review 5.  Human pluripotent stem cell-derived cardiac stromal cells and their applications in regenerative medicine.

Authors:  Martha E Floy; Taylor D Mateyka; Koji L Foreman; Sean P Palecek
Journal:  Stem Cell Res       Date:  2020-04-27       Impact factor: 2.020

6.  Secretome studies of mesenchymal stromal cells (MSCs) isolated from three tissue sources reveal subtle differences in potency.

Authors:  Vijay Bhaskar Reddy Konala; Ramesh Bhonde; Rajarshi Pal
Journal:  In Vitro Cell Dev Biol Anim       Date:  2020-10-02       Impact factor: 2.416

7.  Induction of Fibrogenic Phenotype in Human Mesenchymal Stem Cells by Connective Tissue Growth Factor in a Hydrogel Model of Soft Connective Tissue.

Authors:  Aidan B Zerdoum; Eric W Fowler; Xinqiao Jia
Journal:  ACS Biomater Sci Eng       Date:  2019-07-30

8.  Differences in synovial fibrosis relative to range of motion in knee osteoarthritis patients.

Authors:  Sydney Hodgeson; Sarah O'Brien; Jennifer Simkin; Elena Plakotaris; Christina McCarthy; Vinod Dasa; Luis Marrero
Journal:  J Orthop Res       Date:  2021-05-11       Impact factor: 3.494

Review 9.  Salvadora persica: Nature's Gift for Periodontal Health.

Authors:  Mohamed Mekhemar; Mathias Geib; Manoj Kumar; Yasmine Hassan; Christof Dörfer
Journal:  Antioxidants (Basel)       Date:  2021-04-30

10.  Estradiol Upregulates the Expression of the TGF-β Receptors ALK5 and BMPR2 during the Gonadal Development of Schizothorax prenanti.

Authors:  Taiming Yan; Songpei Zhang; Yueping Cai; Zhijun Ma; Jiayang He; Qian Zhang; Faqiang Deng; Lijuan Ye; Hongjun Chen; Liang He; Jie Luo; Deying Yang; Zhi He
Journal:  Animals (Basel)       Date:  2021-05-11       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.